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in vivo
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Neural crest (NC) cells are multipotent stem cells that arise from the embryonic ectoderm, delaminate 
from the neural tube in early vertebrate development and migrate throughout the developing embryo, 
where they differentiate into various cell lineages. Here we show that multipotent and functional NC 
cells can be derived by induction with a growth factor cocktail containing FGF2 and IGF1 from cultures 
of human inter-follicular keratinocytes (KC) isolated from elderly donors. Adult NC cells exhibited longer 
doubling times as compared to neonatal NC cells, but showed limited signs of cellular senescence 
despite the advanced age of the donors and exhibited significantly younger epigenetic age as compared 
to KC. They also maintained their multipotency, as evidenced by their ability to differentiate into all 
NC-specific lineages including neurons, Schwann cells, melanocytes, and smooth muscle cells (SMC). 
Notably, upon implantation into chick embryos, adult NC cells behaved similar to their embryonic 
counterparts, migrated along stereotypical pathways and contributed to multiple NC derivatives in 
ovo. these results suggest that KC-derived NC cells may provide an easily accessible, autologous source 
of stem cells that can be used for treatment of neurodegenerative diseases or as a model system for 
studying disease pathophysiology and drug development.
The neural crest (NC) is a stem cell population, unique to vertebrates, that arises in vertebrate embryos during 
nervous system formation1. From their site of origin in the forming central nervous system, neural crest stem 
cells delaminate and migrate throughout the peripheral system of the developing embryo. Subsequently, they 
differentiate into various cell types including peripheral neurons, glia, cardiac outflow tract smooth muscle cells, 
melanocytes, adipocytes as well as chondrocytes and osteoblasts of the craniofacial skeleton2. Therefore, they 
represent a cell population with great potential for use in cell replacement for regenerative medicine.
In vitro, NC cells have been derived from embryonic stem cells and induced pluripotent stem cells3,4, as well as 
with direct reprogramming from fibroblasts by introduction of transcription factors, such as Sox105 or FOXD36. 
Interestingly, NC cells have also been isolated from various adult tissues including dorsal root ganglia, gut, heart, 
olfactory sheath, hair follicles and craniofacial tissue2,7–9. These cells maintain their multipotency as they can be 
coaxed to differentiate into neuronal and glial cells10–17, smooth muscle cells10,12,14, melanocytes14,18, bone cells18–23, 
adipocytes10,18–20, and chondrocytes10,14,18. As a result, several groups have proposed their use in applications 
including treatment for spinal cord injury24, deafness25, ocular repair26–28 or periodontal regeneration29. However, 
clinical application is hampered by the need for genetic modification in reprogramming or the limited accessibil-
ity of adult tissues where they reside.
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Recently, we showed that NC cells can be derived from neonatal keratinocytes of the interfollicular epidermis, 
without introduction of transcription factors or reprogramming to pluripotency30. However, it was not clear 
whether multipotent and functional NC cells can be derived from the adult epidermis of aged donors, who have 
the greatest need for cell therapies. Here we show that adult NC cells from elderly donors can also be obtained 
from epidermal cultures by treatment with a growth factor cocktail containing FGF2 and IGF1. Adult NC cells 
derived from KC cultures (KC-NC) from different donors expressed key NC markers including transcription 
factors SOX10, FOXD3, PAX3 and intermediate filament protein, NES. Surprisingly, NC cells from aged epi-
dermal tissues showed limited signs of cellular senescence and younger epigenetic age than epidermal KC. They 
also maintained their multipotency as evidenced by differentiation into all NC-specific lineages including neu-
rons, Schwann cells, melanocytes, and smooth muscle cells (SMC). Most notably, lineage tracing experiments 
by implantation into chick embryos showed that KC-NC from aged donors could migrate along stereotypical 
pathways and differentiate into multiple NC derivatives in ovo, including neurons, glia, SMC and putative mel-
anoblasts. Given the multipotency of KC-NC and the accessibility of human epidermis, our results suggest that 
KC-NC have great potential as an autologous cell source for regenerative medicine and stem cell biology.
Materials and Methods
Isolation of epidermal cells. Skin from the right thigh of human cadavers ranging from 67 to 93 years of 
age was obtained from Gross Anatomy Lab of the University at Buffalo in accordance with appropriate guidelines 
and regulations. Written informed consent was provided before death by the donors who donated their bod-
ies to the University at Buffalo for teaching purposes, scientific research or such purposes as the University, or 
its authorized representatives, shall in their sole discretion deem advisable. The UB Institutional Review Board 
(IRB) determined that researchers using any materials from those donors do not need to get specific permission 
as UB already has blanket permission to use them as needed. The skin of the donors was harvested as it became 
available and the total number of donors used in this study was n = 11 (10 male and 1 female). After washing 
three times with phosphate-buffered saline (PBS), the skin tissues were dissected into small pieces (~1 cm × 1 cm) 
and enzymatically digested using dispase II protease (Sigma, St. Louis, MO) for 15–20 hr at 4 °C. The epider-
mis was separated from the dermis manually using fine forceps and then treated with trypsin-EDTA (0.25%) 
(Life Technologies, Carlsbad, CA) for about 10–15 min at 37 °C. After filtering through a 70 μm cell strainer (BD 
Biosciences, Franklin Lakes, NJ), the cell suspension was centrifuged and resuspended in keratinocyte growth 
medium (KCM) containing 3:1 mixture of DMEM (high glucose) and Ham’s F-12 medium (Life Technologies) 
supplemented with 10% (v/v) fetal bovine serum (FBS, Atlanta Biologicals, Flowery Branch, GA), 100 nM cholera 
toxin (Vibrio Cholerae, Type Inaba 569 B, Millipore, Burlington, MA), 5 μg/ml transferrin (Life Technologies), 
0.4 μg/ml hydrocortisone (Sigma), 0.13 U/ml insulin (Sigma), 1.4 × 10−4 M adenine (Sigma), 2 × 10−9 M triio-
do-L-thyronine (Sigma), 1x antibiotic-antimycotic (Life Technologies) and 10 ng/ml epidermal growth factor 
(EGF, added 3 days post-seeding, BD Biosciences). The resuspension was then cultured on a monolayer of growth 
arrested 3T3-J2 mouse fibroblast feeder cells. The harvested cells that were cultured in KCM formed colonies in 8 
–10 days and the feeder cells were removed using versene treatment for about 10 min at 37 oC. The remaining cells 
were treated with trypsin-EDTA (0.25%); the trypsin was neutralized with PBS containing 10% FBS and the cells 
were cultured on collagen type I coated tissue culture plates (10 μg collagen type I per cm2; BD Biosciences) in 
keratinocyte serum free growth medium (KSFM, Epilife medium with Human Keratinocyte Growth Supplement, 
Life Technologies) until NC induction. KC were used immediately after isolation (passage 1) for all experiments. 
Neonatal cells were isolated from glabrous neonatal (1- to 3-day-old neonates) foreskin tissues that were obtained 
from the John R. Oishei Children’s Hospital, Buffalo, NY according to IRB of John R. Oishei Children’s Hospital. 
Samples were regularly discarded tissues from foreskin circumcisions. Since there was not any identifying data 
from patients, an exemption for obtaining patient consent was granted by IRB of John R. Oishei Children’s 
Hospital. All protocols were in accordance with appropriate guidelines and regulations.
Induction of neural crest stem cells. To obtain NC cells, KC were cultured at a density of 3–5 × 103 cells/
cm2 on collagen I coated tissue culture plates and exposed to Neural Crest Induction Medium (NCIM) containing 
basal medium (EBM2 medium; Lonza, Basel, Switzerland) supplemented with 2% (v/v) FBS, 10 µg/ml heparin 
(Lonza), 100 µg/ml ascorbic acid (Lonza), 0.5 µg/ml hydrocortisone, 1x Gentamicin/Amphotericin-B (Lonza), 
10 ng/ml fibroblast growth factor 2 (FGF2, Isokine, Iceland), and 10 ng/ml Insulin like growth factor 1 (IGF1, 
Lonza). After 2–3 days of induction, NC cells could be seen surrounding KC colonies and by day 10 they had pro-
liferated extensively occupying almost the areas between KC colonies. At that time, NC cells were separated from 
KC by differential trypsinization for about 3 min and re-plated for further experiments. NC cells were derived 
from all donors (n = 11) and each assay as described below was conducted with cells from at least n = 3 donors.
Immunostaining and fluorescence microscopy. After washing with PBS, the cells were fixed with 4% 
(v/v) paraformaldehyde (10 min, room temperature (RT); Sigma), permeabilized using 0.1% (v/v) triton X-100 
(Sigma) for 10 min at RT, washed 3 times with PBS and blocked with 0.01% (v/v) triton X-100 and 5% (v/v) 
normal goat serum (Life Technologies) in PBS. Then cells were incubated with primary antibodies overnight 
at 4 °C, followed by 1 hr incubation with secondary antibody (Alexa 488- or Alexa 594-conjuated anti-IgG anti-
body, Thermo Fisher Scientific, Grand Island, NY, 1:200 dilution) at RT and counterstained with Hoechst 33342 
(Thermo Fisher Scientific) for 5 min at RT. Cells incubated with only secondary antibody served as negative con-
trols. Images were taken using a Zeiss Axio Observer Z1 inverted microscope with an ORCA-ER CCD camera 
(Hamamatsu, Japan). The images were captured using fixed exposure time for each fluorescent dye for all samples. 
Fluorescence intensity and cells numbers were quantified using NIH ImageJ.
3Scientific RepoRts |          (2019) 9:9750  | https://doi.org/10.1038/s41598-019-46140-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
Mitochondrial membrane potential. MitoTracker Red CMXRos (Thermo Fisher Scientific) was used per 
manufacturer’s instructions in order to assess mitochondrial membrane potential. Briefly, cells were incubated for 
10 min in staining solution containing 100 μM MitoTracker® probe, washed 3 times with PBS and counterstained 
with the nuclear dye Hoechst 33342.
Determination of Ros. Mitochondrial superoxide was assessed using the MitoSOX™ Red Mitochondrial 
Superoxide Indicator (Thermo Fisher Scientific) per manufacturer’s instructions. Briefly, cells were incubated for 
10 min with 5 μM MitoSOX™ reagent working solution, washed gently 3 times with PBS and counterstained with 
the nuclear dye Hoechst 33342.
DNA methylation age of KC and NC cells.  KC were isolated from 3 different neonatal and 3 different 
adult donors. After isolation, KC were passaged in KSFM and then treated with NCIM for 9–11 days to obtain 
NC cells. Human cell samples were collected and stored in DNA/RNA Shield™ buffer (www.zymoresearch.com–
Cat. No. R1150, Zymo Research, Irvince, CA). Genomic DNA was purified from cells using the Quick-DNA™ 
Miniprep Plus Kit (Cat. No. D4068, Zymo Research) and quality controls were done by Nanodrop. Bisulfite 
conversion was performed using the EZ DNA Methylation-Lightning™ Kit (Cat. No. D5030, Zymo Research) 
according to the standard protocol. Samples were then enriched for sequencing of >500 age-associated gene 
loci. DNA methylation values of KC and NC stem cell samples were obtained from the sequence data and used to 
assess DNA age according to Zymo Research’s proprietary DNAge® predictor.
Gel compaction assay and vasoreactivity assay for testing adult NC-derived smooth muscle cell 
function. To measure the function of NC-derived SMC, we employed two assays as published previously: the 
gel compaction and the vascular contractility assays31,32. For the gel compaction assay, NC-derived SMC or human 
aortic SMC (ASMC; Life Technologies) were mixed with 0.8 ml of fibrinogen (Enzyme Research Laboratories, South 
Bend, IN). The mixture then was polymerized using 0.2 ml of thrombin (Sigma) in a 24-well plate at 37 °C for 1 hour. 
The final concentration of fibrinogen and thrombin in the fibrin hydrogel was 2.5 mg/ml and 2.5 U/ml, respectively. 
After 1 hr, the fibrin gels were detached from the walls using a fine needle, enabling the gel to compact. Images were 
taken at the indicated times (0, 24, 48, 72, and 96 hr) by ChemiDoc Imaging system (BioRad, Hercules, CA) and the 
area of each hydrogel (A) was measured over time using ImageJ and normalized to the initial hydrogel area (A0).
The vascular contractility, also known as vasoreactivity assay was performed as described previously31,32. 
Briefly, fibrin hydrogels containing NC cells, NC-derived SMC, or control human aortic SMC (HASMC, 106 
cells/ml) were polymerized around a 6-mm diameter mandrel of poly (di-methyl siloxane) to form cylindrical 
constructs. After 1 hr of incubation, hydrogels were detached from the walls and incubated in Tissue Engineered 
Vessel (TEV) medium containing DMEM and 10% FBS supplemented with 2 μg/ml insulin (Sigma), 2 ng/ml 
TGF-β1 (Biolegend, San Diego, CA), 300 μM ascorbic acid phosphate (Alfa Aesar, Tewksbury, MA), and 2 mg/ml 
e-amino-n-caproic acid (Sigma) for 2 weeks. After 2 weeks, tissues were released from the mandrels and mounted 
on two hooks through the lumen in tissue bath containing Krebs–Ringer solution at 37 °C. Hydrogels were equil-
ibrated at a basal tension of 1.0 g and constant length for approximately 45–60 min. After equilibration, isometric 
contractions were recorded in response to vascular agonists: (endothelin-1, 20 nM), the thromboxane A2 mimetic 
U46619 (1 μM) or potassium chloride (KCl, 118 mM). Relaxation of maximally contracted tissue constructs was 
measured in response of Y27632 (10 mM) using a PowerLab data acquisition unit and analyzed with Chart5 soft-
ware (ADInstruments, Colorado Springs, CO).
Differentiation of adult NC cells into NC derivatives. Schwann cell differentiation. Adult NC cells 
were plated on poly-L-ornithine/laminin coated plates and cultured in Schwann cell (SC) differentiation medium 
containing EBM2 as basal medium, 2% (v/v) FBS, 100 ng/ml ciliary neurotrophic factor (Life Technologies), 
100 ng/ml NRG1, 4 ng/ml FGF2, 200 mg/ml ascorbic acid, 0.5× Glutamax (ThermoFisher Scientific), and 10 μM 
SB431542 (Sigma) for 5 weeks.
Melanocyte differentiation. Adult NC cells were cultured in EBM2 basal medium supplemented with 5% FBS, 
SCF (100 ng/ml), endothelin-3 (200 nM), WNT1 (50 ng/ml), FGF2 (10 ng/ml), insulin (5 μg/ml), cholera toxin 
(1 pM), 12-O-tetra-decanoylphorbol-13-acetate (TPA, 10 nM; Sigma) and SB431542 (10 μM) for five weeks. At 
that time, we examined melanin secretion, using the L-DOPA assay, for which adult NC-Mel were fixed with 4% 
(w/v) paraformaldehyde for 20 min at room temperature. After washing three times with PBS, the cells were incu-
bated with freshly prepared 5 mM L-DOPA (Sigma) overnight at 37 °C, fixed with 4% (v/v) paraformaldehyde for 
20 min at RT, washed with PBS and visualized using bright field microscopy.
Smooth muscle cell (SMC) differentiation. KC-NC were induced to SMC in DMEM plus 10% (v/v) FBS and 
10 ng/ml TGF-β1 for two weeks. ASMC were used as the positive control.
Peripheral neuron differentiation. Adult NC cells were cultured on poly-L ornithine (100 ng/ml; Sigma)/laminin 
(10 mg/ml; EMD Millipore, Billerica, MA) coated dishes and exposed to neuron differentiation media containing 
Neurobasal plus medium (Thermo Fisher Scientific) with BMP2 (10 ng/ml; R&D systems, Minneapolis, MN), 
SB431542 (10 μM), B27 plus (Thermo Fisher Scientific), N2 supplement (R&D systems), Brain-derived neuro-
trophic factor (BDNF; 10 ng/ml; Thermo Fisher Scientific), Glial cell-derived neurotrophic factor (GDNF;10 ng/
ml; Sigma), Nerve growth factor (NGF; 10 ng/ml; R & D systems), Neurotrophin 3 (NT3; 10 ng/ml; Sigma), ascor-
bic acid (200 μM; Sigma) and cyclic adenosine monophosphate (0.5 mM cAMP; Sigma), CHIR 99021 (0.5 μM, 
only on day 1; Sigma), 2% FBS (from day 1–5), IWP-4 (100 nM days 4–6; 1 μM thereafter; Tocris Bioscience, 
Minneapolis, MN).
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In ovo transplantation. Adult NC stem cells were transduced with lentivirus containing CMV promoter 
driving expression of the ZsGreen+ reporter. About 50–60% of cells were ZsGreen+ as evidenced by fluores-
cence microscopy. KC-NC or control KC were dissociated using 2 mL of Accuprime (#AM-105, Innovative Cell 
Technologies Inc., San Diego, CA) and incubated at 37 °C for 5 minutes. The cells were washed twice with 1 mL 
of Ringer’s balanced salt solution, and spun down for 7 minutes at 200 G, resuspended into 10 to 20 µL of cell 
medium, and loaded into a thin pulled glass needle pipette. The cells were injected into the migratory cranial NC 
stream of Hamburger-Hamilton Stage 9–12 chick embryos. In total, 157 embryos were successfully injected with 
experimentally induced NC cells, and 55 with control cells. Embryos were examined for visible GFP fluorescence 
under a Leica fluorescent microscope to determine the efficiency of injections, covered with sterile surgical tape, 
and incubated at 37 °C. After 48–72 hours, the surviving embryos were dissected out, fixed with 4% paraformal-
dehyde in PBS overnight at 4 °C and washed 3 times with PBS. Thirty-nine experimental embryos (25% survival 
rate) and 19 control embryos (35% survival rate) survived and were processed.
Fixed embryos were embedded in gelatin and sectioned transversely at 14 µm on a cryostat. Sections were 
examined under a fluorescent Apotome microscope (Zeiss Axioscope 2 and Zeiss ApoTome.2) for GFP sig-
nal. Sections containing GFP positive cells were blocked with a 2.5% goat and 2.5% donkey serum solution in 
PBS-Tween 0.2%, and antibodies were added to the same blocking solution. Immunostaining was performed with 
the following antibodies: for glia, BLBP (ABN14, EMD Millipore, 1:200, antigen retrieval was performed by plac-
ing slides in sodium citrate buffer, pH 6, in a 68 °C water bath overnight, prior to blocking); for neurons HuC/D 
(Invitrogen/molecular probes 16A11 1:100); for smooth muscle, αSMA (Sigma A5228 1:2000); for nuclei, DAPI 
(1:1000). Secondary Alexa dye-conjugated antibodies (Molecular Probes) were used at 1:1000. Slides were imaged 
using fluorescence microscopy (Zeiss Axioscope 2 and Zeiss ApoTome.2).
Results
Adult neural crest stem cells derived from keratinocyte cultures. Previously we showed that neu-
ral crest stem (NC) cells can be isolated from the interfollicular epidermis of glabrous skin from 1–3 day old 
neonates. However, it was not clear that NC-like cells can also be derived from adult epidermis. To this end, we 
derived NC cells from epidermal KC of human skin tissues of adult donors ranging from 67 to 93 years of age 
(n = 11 donors). KC were initially cultured in calcium free medium (KSFM). When the medium was changed 
to the NC induction medium (NCIM consisted of EBM2 basal medium containing FGF2, IGF1, ascorbic acid, 
hydrocortisone, heparin, and 2% FBS), KC formed colonies that were surrounded by a number of small, spin-
dle shaped cells 5–6 days later. Immunostaining showed that these cells expressed key epidermal NC markers 
including lineage-specific transcription factors such as SOX10, FOXD3, PAX3, the NGF receptor (NGFR) and 
the intermediate filament protein, NES (Fig. 1A). Almost all cells expressed NES; the vast majority expressed Pax3 
(92.68 ± 6.75%), FoxD3 (97.3 ± 0.99%) and NGFR (87.7 ± 4.01%), while about 40.0 ± 2.96% of cells were positive 
for Sox10 after 14 days in NCIM (4 fields of view containing n ≥ 500 cells) (Fig. 1B).
Aging hallmarks in adult NC cells.  Next, we examined the aging hallmarks in NC cells from neonatal vs. 
adult donors that were cultured only for one passage, in order to capture differences due to donor age rather than 
replicative senescence. NC cells from aged donors could be maintained in culture for at least 3 passages with an 
average doubling time of 49.45 ± 1.73 hr (n = 2 donors) (Fig. 2A), which was significantly longer than that of neo-
natal NC cells (28.45 ± 1.1 hr, n = 2 donors, p < 0.05). In addition, a small percentage of adult NC cells expressed 
senescence-associated-β-galactosidase (SA-β-Gal, neonatal: 0% vs. adult: 9.81 ± 2.01%, p < 0.0001, n ≥ 600 cells) 
(Fig. 2B).
Interestingly, immunostaining did not show significant differences between the neonatal and adult NC cells with 
respect to the DNA damage marker γH2AX (fluorescence intensity (FI) per cell for neonatal:1.0 ± 0.08 vs. adult: 
0.94 ± 0.21, p > 0.05, n ≥ 400 cells) (Fig. 2C and Fig. S1) or expression of senescence associated markers p16 or 
p53 (p16, FI for neonatal: 1 ± 0.14 vs. adult = 0.95 ± 0.03, p = 0.6381; p53, neonatal: 1 ± 0.03 vs. adult: 1.18 ± 0.11, 
p = 0.1120, n = 3 donors) but they showed upregulation of p21 (p21: FI for neonatal: 1 ± 0.06 vs. adult: 2.21 ± 0.46, 
p = 0.039, n = 3 donors) (Fig. 2C and Fig. S1). Finally, adult NC cells showed similar levels of superoxide (MitoSox, 
FI for neonatal: 1 ± 0.22 vs. adult: 1.52 ± 0.241, p = 0.534, n = 3 donors) (Fig. 2D) and mitochondrial membrane 
potential (FI for neonatal: 1 ± 0.13 vs. adult: 1.28 ± 0.15, p = 0.1096) (Fig. 2E) as compared to neonatal NC.
epigenetic age of adult KC and KC-derived NC. Recent publications have shown chronological age has 
a profound effect on genome-wide DNA methylation levels and that methylation of CpG dinucleotides can be 
used to predict the epigenetic age or else known as DNA methylation-based (DNAm) age of human tissues and 
cells using linear regression algorithms or epigenetic “age estimators” such as the Horvath clock33–35. Since we did 
not observe significant differences in several aging hallmarks between adult and neonatal KC-NC despite the large 
difference in the chronological age of the donors, we employed this method to determine the DNAm age of KC 
and KC-NC from neonatal and adult donors. Principle component analysis (PCA) of the differentially methylated 
CpG regions in KC and KC-NC from 3 neonatal and 3 adult donors showed clustering into four distinct groups 
(Fig. S2A), indicating differences between cell types but also between different age donors. Moreover, a heat map 
and associated dendrogram showed that although there were differences between the methylation profiles of 
adult and neonatal cells, the biggest differences were seen between the two cell types, KC and KC-NC (Fig. S2B). 
Finally, linear regression calculations based on the Horvath clock algorithm showed that the DNAm age of adult 
KC (85.96 ± 8.47 years; n = 3 donors) was similar to the chronological age of adult donors (80.33 ± 9.97 years; 
p = 0.497, n = 3 donors;). Surprisingly, the predicted DNAm age of adult KC-NC (40.33 ± 9.19 years; n = 3 
donors) was significantly younger than the chronological age of the donors (80.33 ± 9.97 years; p = 0.007, n = 3 
donors), suggesting that NC cells may be aging much more slowly than KC (Fig. 2F). These results suggested that 
NC cells may retain their multipotency despite the late age of the donors.
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Differentiation of adult NC cells to functional neural crest derivatives. To address this hypothesis, 
we examined the propensity of adult KC-NC to differentiate into NC derivatives, including Schwann cells, neu-
rons, melanocytes and smooth muscle cells.
Schwann cells. NC cells differentiated into Schwann cells in the presence of differentiation medium containing 
EBM2 basal medium supplemented with 2% FBS, 100 ng/ml CNTF, 100 ng/ml NRG1, 4 ng/ml FGF2, 200 µg/ml 
ascorbic acid and 0.5x Glutamax, for 5 weeks. Immunostaining showed that almost all the cells were positive for 
S100B, PLP1, and MPZ (Fig. 3A).
Figure 1. Adult NC cells derived from keratinocyte cultures express NC specific markers. (A) Immunostaining 
of adult NC cells for SOX10, FOXD3, PAX3, NGFR and NESTIN. Scale bar is 100 μM. (B) Percentage of adult 
NC cells expressing SOX10, FOXD3, PAX3, and NGFR after two weeks of culture. All values are mean ± SD. 
Each experiment was repeated three times.
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Peripheral neurons. NC cells differentiated into peripheral neurons using neuron differentiation medium 
(Neurobasal plus media with BMP2 (10 ng/ml), SB431542 (10 μM), B27 plus, N2 supplement, Brain-derived neu-
rotrophic factor (BDNF; 10 ng/ml), Glial cell-derived neurotrophic factor (GDNF; 10 ng/ml), Nerve growth factor 
Figure 2. Aging hallmarks in NC derived from adult and neonatal KC. (A) Proliferation kinetics. (B) SA-
β-Gal staining and quantification. (C) Quantification of the staining intensity of γH2AX, P16, P21, and P53 
normalized to the intensity of neonatal NC cells. (D) Total reactive oxygen species (ROS) in adult vs. neonatal 
NC cells evaluated using the MITOSOX reagent. (E) Mitochondrial membrane potential of adult vs. neonatal 
NC cells. Scale bar is 100 μm. (F) DNA methylation age of adult and neonatal KC and KC-NC. All values are 
mean±SD. Each experiment was repeated three times.
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(NGF; 10 ng/ml), Neurotrophin 3 (NT3; 10 ng/ml), Ascorbic acid (200 μM) and cyclic adenosine monophosphate 
(0.5 mM cAMP), CHIR 99021 (0.5 μM, only on day 1), 2% FBS (from day 1–5), IWP4 (100 nM days 4–6; 1 μM 
thereafter). After 14 days in differentiation medium, the cells developed long processes and expressed typical 
neuronal markers such as Peripherin (83.85 ± 0.3%, n = 567 cells) and TUBB3 (59.48 ± 0.2%, n = 1,832 cells) 
(Fig. 3B,C).
Melanocytes. For melanocyte differentiation, NC cells were cultured in EBM2 basal medium supplemented 
with 5% FBS, SCF (100 ng/ml), endothelin-3 (200 nM), WNT1 (50 ng/ml), FGF2 (10 ng/ml), insulin (5μg/ml), 
cholera toxin (1 pM), 12-O-tetra-decanoylphorbol-13-acetate (TPA, 10 nM) and SB431542 (10 μM). After 5 
Figure 3. Differentiation of adult KC-NC to functional neural crest derivatives. Immunostaining for (A)
Schwann cell specific markers including. S100B, PLP1, and MPZ, and (B) peripheral neuron specific markers, 
Peripherin and TUBB3. (C) Phase image shows the morphology of adult NC-derived neurons. (D) Melanocyte 
specific markers MITF and PMEL. Scale bar is 100 μm. (E) L-DOPA assay showing melanin secretion indicating 
tyrosinase activity.
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weeks of differentiation, 52 ± 6.33% of the cells expressed the melanocyte-specific transcription factor, MITF 
and 40 ± 6.61% expressed the pre-melanosome transmembrane glycoprotein, PMEL (n = 780 cells) (Fig. 3D). 
Notably, NC-derived melanocytes produced melanin, clearly indicating tyrosinase activity–specific for melano-
cytes –as evidenced by the L-DOPA assay (Fig. 3E).
Smooth muscle cells. NC cells were coaxed to differentiate into SMC in DMEM supplemented with 10μg/ml 
TGF-β1 for two weeks. Almost all of the NC-SMC showed positive staining for ACTA2, CALD1 and MYH11, and 
about 92.85 ± 8.5% (n = 308 cells) expressed CNN1 (Fig. 4A).
In addition, we examined the contractile function of NC-SMC using two well-established assays: hydrogel 
compaction and contractility (or vasoreactivity). For hydrogel compaction, cells were embedded in fibrin hydro-
gels that were allowed to compact over time. As shown in Fig. 3B, NC-SMC compacted fibrin hydrogels over time 
down to less than 20% of their initial area (96 hr), which was very similar to compaction by human aortic (hA)
SMC (Fig. 4B).
For vasoreactivity, we prepared cylindrical tissue equivalents by embedding cells (NC cells, NC-SMC or 
HASMC) in fibrin hydrogels that were polymerized around cylindrical mandrels, as we published before31,36,37. 
After two weeks in culture in the presence of TGF-β1, the cells compacted the hydrogels down to ~5% of their 
Figure 4. Differentiation of adult KC-NC to functional SMC. (A) Immunostaining of SMC specific markers 
including ACTA2, CALD1, CNN1, and MYH11. (B) Hydrogel compaction of HASMC and NC-SMC. (C) 
Vasoreactivity of HASMC, NC-SMC, and NC cells based bioengineered vascular constructs in response to 
U46619, Endothelin-1, KCl, and Y27632. All values are mean ± SD of triplicates. Each experiment was repeated 
three times.
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original volume yielding cylindrical constructs with wall thickness of less than 500 µm. At that time, rings 
of tissue constructs were placed in isolated tissue baths to measure isometric tension generated in response to 
several vascular agonists: the thromboxane A2 mimetic U46619, Endothelin-1, and KCl as well as the vasodi-
lator, Y27632 (Fig. 4C). Reactivity of NC-SMC based tissue constructs was comparable (KCl, p = 0.2730, n = 3) 
or superior (U46619, p < 0.01, n = 3; ET-1, p < 0.05, n = 3; or Y27632, p < 0.05, n = 3) to that of hASMC based 
tissues. Interestingly, NC cells differentiated into functional SMC in 3D, although differentiating NC cells into 
SMC (NC-SMC) prior to generating the 3D constructs resulted in even higher contractility in response to U46619 
(p < 0.05, n = 3). These results indicate that functional adult KC-NC differentiated into functional, contractile SMC.
NC cells migrate and differentiate into NC lineages in ovo. Next, we performed lineage tracing 
experiments to examine the ability of KC-NC to migrate towards stereotypical pathways in vivo. To this end, 
ZsGreen labeled KC or KC-NC that were transplanted into the head mesenchyme of 8–13 somite host chick 
embryos (Fig. 5B) were analyzed either 48 hours (n = 16) or 72 hours (n = 23) post-transplantation. The results 
showed that KC-NC were predominantly detected in locations populated by neural crest-derived cells (Fig. 5A). 
The majority, 60% of the KC-NC (227 cells out of 382; n = 8) localized to cranial ganglia, significantly different 
from only 7% of the control KC (18 cells out of 253; n = 6, p = 0.002). Similarly, 14% of the KC-NC (54 cells 
out of 382; n = 8) were located in the branchial arches as compared to 3% of KC controls (7 out of 253; n = 6), 
although the results were not statistically significant (p = 0.59). The KC-NC contributed to the full repertoire of 
NC derivatives, from HuC/D expressing neural (Fig. 5D) and BLBP positive glial cells (Fig. 5F), to mesenchy-
mal αSMA positive smooth muscle lining the blood vessel walls (Fig. 5E). KC-NC also gave rise to presumptive 
melanoblasts below the ectoderm, although the time point for the analysis was too early to detect the melanocyte 
lineage marker MitF (Fig. 5C). In contrast, 75% (189 cells out of 253; n = 6 embryos) of control KC were pref-
erentially found in the mesenchyme, corresponding to the original site of injection, whereas only 14% (52 cells 
out of 382; n = 8) of KC-NClocalized in the mesenchyme (p = 0.0013). These results show that KC-NC behave 
similarly to embryonic NC cells in ovo and can contribute to multiple NC derivatives, providing strong support 
of NC phenotype.
Discussion
We previously found that neural crest (NC) stem cells could be derived from neonatal human epidermal kerati-
nocytes (KC) without genetic introduction of transcription factors or reprogramming to the pluripotent state30,38. 
However, it was not clear whether NC cells could also be derived from the skin of adult donors, who are most 
likely in need of cellular therapies. Here we report for the first time that NC cells can be obtained from the epider-
mis of older adult donors ranging from 67 to 93 years of age. Adult NC cells derived from KC cultures expressed 
key NC markers including lineage-specific transcription factors such as SOX10, FOXD3, PAX3, the interme-
diate filament protein, NES and cell surface receptor, NGFR (p75NTR), similar to that observed with neonatal 
KC-NC30,38.
Previous studies showed that NC cells from different sources including gut, DRG, bone marrow, and hair bulge 
could be maintained in culture for short times, up to two passages39. Embryonic neural crest cells in traditional 
adherent cultures also showed limited self-renewal capacity40,41, which could be enhanced significantly when cells 
were cultured in 3D spheroids, termed crestospheres40. This result is in agreement with previous reports that 3D 
spheroid cultures enhanced the proliferation and differentiation potential of mesenchymal stem cells42,43, signify-
ing the importance of cell-cell interactions in determining stem cell fate decisions44–46.
Although adult NC cells were derived from elderly donors, only about 10% of them were positive for 
senescence-associated β-galactosidase (SA β-gal), a common marker of cellular senescence47. In addition, they 
did not exhibit DNA damage as evidenced by γH2AX phosphorylation and did not upregulate cell cycle inhibi-
tors such as P16 or P5347,48, but did express higher amounts of P21 as compared to neonatal NC cells. Although 
P21 is expressed through the p53 pathway, it can also be regulated independently49,50. Finally, adult KC-NC did 
not show statistically elevated reactive oxygen species (ROS), the product of impaired electron transport chain in 
mitochondria, which is known to be associated with cellular and organismal aging48. These results suggested that 
KC-NC may be epigenetically “younger” than the epidermis of the donors.
Many studies have suggested that chronological age has a significant effect on epigenetic modifications, such 
as DNA methylation levels34,51–55. In addition, mathematical algorithms have been developed to estimate the 
biological age of cells or tissues based on the methylation levels of sets of CpG islands. The biological age is also 
known as epigenetic age or DNA methylation age (DNAm age)33,56,57 and has been shown to be an accurate pre-
dictor of chronological age. Interestingly, application of the Horvath epigenetic algorithm as applied to 538 CpG 
showed that KC and KC-NC from the same donors exhibited significantly different DNAm age. While the DNAm 
age of KC was about the same as that of the donors (about 80 years), KC-NC were significantly “younger”, with 
DNAm of almost half (~40 years). Although the reason for this difference is not clear, we speculate that while 
KC stem cells need to proliferate frequently in order to regenerate the epidermis multiple times during a person’s 
lifetime, KC-NC may not be under the same evolutionary pressure, thereby “aging” at a slower pace. Alternatively, 
the culture conditions may have reprogrammed KC-NC to a neonatal-like state, essentially re-setting the age 
clock. This result suggested that despite the old age of the donors, KC-NC may have retained their multipotency 
in vitro and perhaps also in vivo.
Indeed, in agreement with our results with neonatal NC cells30, adult KC-NC could be coaxed to differentiate 
into functional neurons, Schwann cells, melanocytes and SMC, in vitro. Most notably, upon transplantation into 
chick embryos, KC-NC migrated along stereotypical pathways and gave rise to multiple NC derivatives, including 
neurons, glial cells, SMC lining the vascular wall and presumptive melanoblasts in the skin. These lineage trac-
ing experiments in chick embryos provide strong support of the phenotype and multipotency of KC-NC. Since 
these cells can be derived from the human epidermis with no genetic modification or reprogramming to the 
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pluripotent state, they have the potential to be used for treatment of neurodegenerative diseases—for which cell 
source remains a significant hurdle—as well as for modeling human diseases of the central or peripheral nervous 
system e.g. neurocristopathies58. Therefore, this readily accessible source of NC cells may have significant impact 
on regenerative medicine as well as understanding human disease and facilitating drug discovery.
Figure 5. Adult KC-NC migrate to neural crest sites and differentiate into appropriate derivatives in ovo. (A) 
Summary of locations in which ZsGreen positive transplanted cells were found in 3–4-day-old chicken embryos 
in representative embryos. Percentage of experimental transplanted cells detected in each target structure in 
the developing chick embryos (n = 8 embryos; total number of detected ZsGreen+ cells = 382 out of ~2000 
transplanted cells) compared with the percentage of control keratinocytes (n = 6 embryos; total number of 
detected ZsGreen+ cells = 253 out of ~3000 transplanted cells). (B) An image showing transplanted ZsGreen+ 
KC-NC in the cranial mesenchyme (cm) of a 8–13 somite (som) host chick embryo immediately after injection; 
neural tube = nt; cm = cranial mesenchyme; som = somite. (C) Putative ZsGreen+ melanocytes 72 hours 
post injection underneath the cranial ectoderm. (D) HuC/D and ZsGreen double-positive neurons within the 
trigeminal ganglion (tgg); fb = forebrain; hb = hindbrain. (E) A SMA+ cranial blood vessel with a ZsGreen/
SMA double positive transplanted cell. (F) ZsGreen/BLBP double positive glial cells (presumably Schwann 
cells) localized in a HuC/D-positive nerve bundle.
1 1Scientific RepoRts |          (2019) 9:9750  | https://doi.org/10.1038/s41598-019-46140-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
Conclusion
We showed that adult NC cells can be derived from human interfollicular KC from older donors without direct 
reprogramming or reprogramming to pluripotency. These cells exhibited younger epigenetic age than KC from 
the same advanced age donors and maintained their multipotency in vitro and in vivo. Given the accessibility of 
human epidermis and ease of isolation, adult KC-NC have great potential for use in stem cell therapy, disease 
modeling and drug discovery for treatment of neurodegenerative disorders.
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